The reckoning begins for biotech-focused SPACs

The reckoning begins for biotech-focused SPACs

Source: 
EP Vantage
News Tags: 
snippet: 

The start of the Spac boom was 2020’s story. This year is about the consummation of deals. But with more special-purpose acquisition companies floating every week, competition for the hands of well-bred private companies is only getting fiercer.